CINV: Affecting Pathways, Optimizing Outcomes: Breakthrough, Delayed, Refractory CINV
0.9 Contact Hours
Expires: 1/30/2009
This newsletter is supported by an unrestricted educational grant from Solvay Pharmaceuticals.

Here is the latest information about the management of breakthrough, delayed and refractory CINV written by clinical experts. This newsletter provides risk factor assessment and treatment information for this difficult condition. In addition, case studies are presented with questions and answers for an immediate understanding of how this information can be applied to specific situations.

Download PDF | Take CNE test | Order Material

Cytokines & B-Cell Malignancies: Maximizing Therapeutic Outcomes
2.6 Contact Hours
Expires: 1/30/09
This program is sponsored by an educational grant from Berlex Oncology, Inc.

This monograph is an independent study for oncology nurses interested in learning about the phenomena of antibody-dependent cell-mediated cytotoxicity in the treatment of B-cell malignancies. The monograph will summarize treatment options and their limitations for follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia as well as summarize data on mechanisms to delay disease relapse.

Order Material | Download PDF | Take CNE test

Delegating Cancer Care Toolkit
Strengthen your delegating skills.

Download Material

Finding the Balance: Providing Patient-Driven, Evidence-Based Treatment and Care
1.6 Contact Hours
Expires: 1/30/09
This monograph is sponsored by an unrestricted educational grant from sanofi-aventis.

This monograph presents thoughtful information regarding individualizing evidence-based treatment options for specific cancer diagnoses. Special attention is given to nursing-sensitive patient outcomes, population-specific care, and financial aspects of care along with information needed to develop individualized patient treatment and support plans utilizing the most recent treatment guidelines for these cancer diagnoses.

Order Material | Download PDF | Take CNE test

The Myeloma Messenger
Contact hours are noted with each edition
Expires 11/01/09
Supported by an educational grant from Millennium Pharmaceuticals.

If you are a NP, CNS, or other ONS member interested in myeloma, you’ll certainly want to participate in this distinctive offering from ONS! You are invited  to view each edition of The Myeloma Messenger and listen to the companion podcasts. This unique combination of newspapers and podcasts share the kind of information you need to care for this patient population. Click here to take part in this series and earn important CNE credit.

Non-Pharmacologic Approaches to the Management of Vertebral Compression Fractures
0.4 Contact Hours
Expires: 10/1/08

The content in this newsletter is complementary to the the webcast. After reading the newsletter, the participant may submit a completed evaluation form and post test for continuing education credit as well. Please take advantage of both learning experiences to gain the best understanding of this topic.

Order | Download | Newsletter